Rockwell Medical (RMTI) Reports Q1 Loss of $0.84/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Rockwell Medical Provides First Quarter 2022 Financial and Operational Update
May 16, 2022 4:02 PM EDT- First quarter net sales of $16.1 million, up 4.2% year-over-year -Â
- Submitted Supplemental Data to FDA for IND Application to enable Phase 2 FPC Home Infusion Trial -
- Amended and expanded supply agreement with DaVita, including $7.5M investment, strengthens Rockwell's financial position, laying groundwork for profitable concentrates business -
- Completion of patient enrollment ahead of schedule in pivotal Phase 3 trial of Triferic® in China -
- Conference call and webcast scheduled for today at 4:15 p.m. ET... More
